Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Vous n'êtes pas connecté
Scientists at the University of Southampton have uncovered how the immune system's natural killer cells can target a protein known as XPO1, which promotes cancer. By hijacking this protein, they may activate more killer cells to destroy cancer cells. This discovery could lead to new, less invasive cancer treatments, showing promise for personalized immunotherapy.
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
A credit-card-sized chip may soon outsmart cancer. A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device...
A credit-card-sized chip may soon outsmart cancer. A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device...
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...
A new comprehensive review reveals that harnessing natural killer (NK) cells by blocking their “off-switches” could significantly enhance cancer...